Great West Life Assurance CO Xenon Pharmaceuticals Inc. Transaction History
Great West Life Assurance CO
- $49.6 Billion
- Q1 2024
A detailed history of Great West Life Assurance CO transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 10,032 shares of XENE stock, worth $369,277. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,032
Previous 5,341
87.83%
Holding current value
$369,277
Previous $244,000
77.05%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding XENE
# of Institutions
228Shares Held
69MCall Options Held
307KPut Options Held
68.9K-
Avoro Capital Advisors LLC New York, NY5.67MShares$209 Million2.94% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.32MShares$159 Million2.04% of portfolio
-
Wellington Management Group LLP Boston, MA3.92MShares$144 Million0.03% of portfolio
-
Capital World Investors Los Angeles, CA2.68MShares$98.7 Million0.02% of portfolio
-
Polar Capital Holdings PLC London, X02.61MShares$96.2 Million0.7% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.29B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...